Large-scale testing (Phase 3)Study completedNCT04973228
What this trial is testing
Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)
Who this might be right for
Seborrheic Dermatitis
Arcutis Biotherapeutics, Inc. 457